Sanara Medtech Inc
NASDAQ:SMTI

Watchlist Manager
Sanara Medtech Inc Logo
Sanara Medtech Inc
NASDAQ:SMTI
Watchlist
Price: 21.69 USD -0.5% Market Closed
Market Cap: 193.9m USD

Sanara Medtech Inc
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Sanara Medtech Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Sanara Medtech Inc
NASDAQ:SMTI
Cash & Cash Equivalents
$14.9m
CAGR 3-Years
13%
CAGR 5-Years
48%
CAGR 10-Years
54%
Haemonetics Corp
NYSE:HAE
Cash & Cash Equivalents
$296.4m
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
11%
ICU Medical Inc
NASDAQ:ICUI
Cash & Cash Equivalents
$299.7m
CAGR 3-Years
7%
CAGR 5-Years
-3%
CAGR 10-Years
-2%
Align Technology Inc
NASDAQ:ALGN
Cash & Cash Equivalents
$190.8m
CAGR 3-Years
-43%
CAGR 5-Years
-21%
CAGR 10-Years
1%
Lantheus Holdings Inc
NASDAQ:LNTH
Cash & Cash Equivalents
$382m
CAGR 3-Years
14%
CAGR 5-Years
34%
CAGR 10-Years
33%
Merit Medical Systems Inc
NASDAQ:MMSI
Cash & Cash Equivalents
$392.5m
CAGR 3-Years
97%
CAGR 5-Years
54%
CAGR 10-Years
52%
No Stocks Found

Sanara Medtech Inc
Glance View

Market Cap
193.7m USD
Industry
Health Care

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 63 full-time employees. The Company’s products include surgical wound care products, which includes CellerateRX Surgical Activated Collagen (Powder and Gel), and chronic wound care products, which include HYCOL Hydrolyzed Collagen (Powder and Gel), BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel. The surgical wound care products are used in specialties including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, oncology, plastic/reconstructive, podiatric, urology and vascular. The chronic wound care products are used across the post-acute continuum of care, including home health, hospice, physician offices, podiatrists, retail, skilled nursing facilities, and wound care centers.

SMTI Intrinsic Value
37.76 USD
Undervaluation 43%
Intrinsic Value
Price

See Also

What is Sanara Medtech Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
14.9m USD

Based on the financial report for Sep 30, 2025, Sanara Medtech Inc's Cash & Cash Equivalents amounts to 14.9m USD.

What is Sanara Medtech Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
54%

Over the last year, the Cash & Cash Equivalents growth was -8%. The average annual Cash & Cash Equivalents growth rates for Sanara Medtech Inc have been 13% over the past three years , 48% over the past five years , and 54% over the past ten years .

Back to Top